And Now Back to Our Regularly Scheduled Programming
The US FDA’s Pediatric Advisory Committee will talk about cardiac and neuropschiatric events possibly relating to ADHD drugs at a March 22nd meeting
Note the word “possibly”. Will be interested to see the results.
